Upstate Active Clinical Trials
Study Title:A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum
What is the purpose of the study?Randomized treatment study to look at the effect of combination chemotherapy in treating young patients with newly diagnosed high-risk acute lymphoblastic leukemia.
Upstate Institutional Review Board (IRB) Number:275126
Patient Age Group:Children
Principal Investigator:Karol H Kerr, MD
Who can I contact for more information?
Name: Beatriz Kovar